The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dacarbazine medac 1000 mg, powder for solution for infusion

1000 milligram(s) Powder for solution for infusion

Medac Gesellschaft fur Klinische Spezialpraparate mbH PA0623/003/004

Main Information

Trade NameDacarbazine medac 1000 mg, powder for solution for infusion
Active SubstancesDacarbazine
Strength1000 milligram(s)
Dosage FormPowder for solution for infusion
Licence HolderMedac Gesellschaft fur Klinische Spezialpraparate mbH
Licence NumberPA0623/003/004

Group Information

ATC CodeL01AX Other alkylating agents
L01AX04 dacarbazine

Status

Authorised/WithdrawnAuthorised
Licence Issued14/11/1997
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back